2.48
0.01 (0.40%)
| Previous Close | 2.47 |
| Open | 2.45 |
| Volume | 1,386,841 |
| Avg. Volume (3M) | 2,789,764 |
| Market Cap | 949,575,360 |
| Price / Earnings (TTM) | 22.55 |
| Price / Sales | 7.62 |
| Price / Book | 0.920 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | 39.69% |
| Operating Margin (TTM) | -10.90% |
| Diluted EPS (TTM) | 0.140 |
| Quarterly Revenue Growth (YOY) | 27.60% |
| Total Debt/Equity (MRQ) | 0.16% |
| Current Ratio (MRQ) | 27.80 |
| Operating Cash Flow (TTM) | 18.95 M |
| Levered Free Cash Flow (TTM) | -28.78 M |
| Return on Assets (TTM) | -2.42% |
| Return on Equity (TTM) | 4.59% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Bullish | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Bullish | Mixed | |
| Stock | Cronos Group Inc. Common Share | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | -0.50 |
|
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 46.73% |
| % Held by Institutions | 14.32% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Chescapmanager Llc | 30 Jun 2025 | 7,950,237 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 13 Nov 2025 | CNBC | Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling |
| 06 Nov 2025 | Announcement | Cronos Group Reports 2025 Third Quarter Results |
| 01 Nov 2025 | CNBC | 'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance |
| 28 Oct 2025 | Announcement | Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season |
| 23 Oct 2025 | Announcement | Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025 |
| 09 Oct 2025 | Announcement | Cronos launches SOURZ by Spinach® Fully Blasted Multipacks |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |